Literature DB >> 19436334

Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice.

Manchang Liu1, Dmitry N Grigoryev, Michael T Crow, Mark Haas, Masayuki Yamamoto, Sekhar P Reddy, Hamid Rabb.   

Abstract

Oxidative stress is involved in acute kidney injury due to ischemia-reperfusion and chemotherapy-induced nephrotoxicity. To investigate their basic mechanisms we studied the role of nuclear factor-erythroid 2-p45-related factor 2 (Nrf2), a redox-sensitive transcription factor that regulates expression of several antioxidant and cytoprotective genes. We compared the responses of Nrf2-knockout mice and their wild-type littermates in established mouse models of ischemia-reperfusion injury and cisplatin-induced nephrotoxicity. Several Nrf2-regulated genes encoding antioxidant enzymes/proteins were significantly upregulated in the kidneys of wild type but not Nrf2-knockout mice following renal ischemia. Renal function, histology, vascular permeability, and survival were each significantly worse in the Nrf2 knockout mice. Further, proinflammatory cytokine and chemokine expression tended to increase after ischemia in the knockout compared to the wild-type mice. Treatment of the knockout mice with the antioxidants N-acetyl-cysteine or glutathione improved renal function. The knockout mice were more susceptible to cisplatin-induced nephrotoxicity, and this was blunted by N-acetyl-cysteine pretreatment. Our study demonstrates that Nrf2-deficiency enhances susceptibility to both ischemic and nephrotoxic acute kidney injury, and identifies this transcription factor as a potential therapeutic target in these injuries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19436334     DOI: 10.1038/ki.2009.157

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  97 in total

1.  Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.

Authors:  Wei Ling Lau; Shu-Man Liu; Sogol Pahlevan; Jun Yuan; Mahyar Khazaeli; Zhenmin Ni; Jefferson Y Chan; Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.

Authors:  Qing Qing Wu; Yanxia Wang; Martin Senitko; Colin Meyer; W Christian Wigley; Deborah A Ferguson; Eric Grossman; Jianlin Chen; Xin J Zhou; John Hartono; Pamela Winterberg; Bo Chen; Anapam Agarwal; Christopher Y Lu
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-02

3.  Resveratrol ameliorates sepsis-induced acute kidney injury in a pediatric rat model via Nrf2 signaling pathway.

Authors:  Yan Wang; Fenling Feng; Minna Liu; Jiahong Xue; Huimei Huang
Journal:  Exp Ther Med       Date:  2018-07-27       Impact factor: 2.447

Review 4.  Nrf2: a potential target for new therapeutics in liver disease.

Authors:  A M Bataille; J E Manautou
Journal:  Clin Pharmacol Ther       Date:  2012-08-08       Impact factor: 6.875

5.  Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.

Authors:  Partha Mukhopadhyay; Béla Horváth; Malek Kechrid; Galin Tanchian; Mohanraj Rajesh; Amarjit S Naura; A Hamid Boulares; Pál Pacher
Journal:  Free Radic Biol Med       Date:  2011-08-17       Impact factor: 7.376

6.  Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.

Authors:  Donald R Senger; Mien V Hoang; Ki Hyun Kim; Chunshun Li; Shugeng Cao
Journal:  J Ethnopharmacol       Date:  2016-09-20       Impact factor: 4.360

7.  Keap1 inhibition attenuates glomerulosclerosis.

Authors:  Yoichi Miyazaki; Akihiro Shimizu; Ira Pastan; Keiko Taguchi; Eriko Naganuma; Takafumi Suzuki; Tatsuo Hosoya; Takashi Yokoo; Akihiko Saito; Toshio Miyata; Masayuki Yamamoto; Taiji Matsusaka
Journal:  Nephrol Dial Transplant       Date:  2014-02-11       Impact factor: 5.992

Review 8.  Filtering through the role of NRF2 in kidney disease.

Authors:  Cody J Schmidlin; Matthew B Dodson; Donna D Zhang
Journal:  Arch Pharm Res       Date:  2019-08-01       Impact factor: 4.946

9.  Overactivation of the nuclear factor (erythroid-derived 2)-like 2-antioxidant response element pathway in hepatocytes decreases hepatic ischemia/reperfusion injury in mice.

Authors:  Lung-Yi Lee; Calvin Harberg; Kristina A Matkowskyj; Shelly Cook; Drew Roenneburg; Sabine Werner; Jeffrey Johnson; David P Foley
Journal:  Liver Transpl       Date:  2016-01       Impact factor: 5.799

10.  The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy.

Authors:  Tao Jiang; Zheping Huang; Yifeng Lin; Zhigang Zhang; Deyu Fang; Donna D Zhang
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.